We are a startup founded in August 2021, delivering quality advisory and implementation services related to Odoo ERP (odoo.com). In Flyt we work with a range of customers within different sectors, from retail to engineering and manufacturing companies. These companies look to us for advice and experience when taking the leap to transform the way they do their work. We aim to build the number one Nordic consultancy within our area, making a concrete impact on our customers, and enabling each other to learn and grow.

We have developed a camera-based sensor for 24h automatic sea lice counting and biomass measurement. Our product solves the main challenges in high contrast underwater imagery of sea lice with deficient maintenance. We are looking for funding to take the effect to the next level, where approval of our solution in the industry and by authorities are key factors as well as the development of the organization.

Kjeller Innovation is creating companies based on ideas from researcher from ten different research institutes and universities at Kjeller, Ås, Oslo, Buskerud and Vestfold. We are always looking for talented people who are interested in working in startups, be investor in startups, be a board member in a startup or just want to know more about our companies.

Investant specializes in the development of software solutions related to algorithmic trading. ​We offer 2 services: IT Consultancy: We can develop bespoke trading solutions suited to your specific needs Software Infrastructure: Leverage our in-house developed infrastructure Trading is hard and requires top-notch technology and brains. As we put years into developing self-learning algorithms we leverage every piece of information we can get our hands on and improve day by day. Our technological head-start is and will be a crucial factor in this strongly growing market.

LANARS ble grunnlagt i 2016. Vi utvikler applikasjoner, nettsider og ferdige løsninger for IoT for våre kunder (for eksempel smarte ringeklokker og systemer for kvalitetskontroll av planter). Vi skaper merverdi og strekker oss langt for å møte våre kunders ønsker og behov. Hovedgrunnen til at kunder velger oss, i tillegg til selve produktet, er vår evne til å forstå behovene og forventningene deres og dermed levere akkurat det de trenger.

NOFO is founded by passionate food lovers and environmentalists with the goal to inspire plant-based eating with a near-zero carbon footprint. We source all organic ingredients from small local farms to support sustainable farming. By only using high-quality ingredients seasonally harvested by local farmers, we are able to give our customers the best that nature has to offer. How we eat is the most important environmental question facing today's society. Living a plant-based lifestyle will significantly lower your carbon footprint by up to 73%. We want you to join the movement and feel inspired

Norwegian, fast-forward moving company set out to save the world by producing highly nutritious bio-mass from microalgae in nature’s own way. Using what others view as waste we copy nature´s own way in an industrial way to create valuable products that could turn into whatever your heart desires - cosmetics, animal feed, nutraceuticals, and food supplements as well as bioplastic and biofuel!

For å møte dine behov har vi testet, tegnet og utforsket utallige materialer. Her kan du se et utvalg prototyper som til slutt resulterte i Mr.Grippy. Det hele startet en vinternatt i 2016. Som studenter med liten plass syntes vi skipreparering var tungvint. Vi tok saken i egne hender og lagde vår første prototype i treverk.

Emberly is a Stavanger-based startup founded in 2020. The company was born out of a desire to help people learn better and to help them manage information overload. Our product is a knowledge library, but in contrast to other solutions, we help you organize your knowledge into what we call "knowledge maps". Traditional solutions based on tags and search are not adequate due to the simple fact that it requires using the language center of the brain, this requires you to break your chain of thought before you can even start looking for your resources. Emberly in contrast, lets you use spatial navigation to find what you are looking for. Which is far more efficient.Not to mention the fact that by creating and using this breakdown of topics, you automatically gain a far better understanding of the concepts you are working on. We have been working tightly knit with our community for two years to help us make Emberly the best experience it can be, and we officially released the system in 2022.

Biozep is discovering and developing first-in-class drug products for the treatment of severe eye diseases which can lead to vision loss and where it is a high unmet medical need. Biozep has discovered novel drug substances based on bioactive lipids which modulate central pathways involved in the pathogenesis of eye diseases. Targets and biomarkers are identified based on a system biology approach combined with in-depth knowledge about bioactive lipids, their endogenous synthesis and mechanisms of action. Biozep has made a prototype drug product based on our lead compound for topical administration and the product will be tested in animal models in 2018. Our goal is to start clinical studies in 2020. Biozep is a company depending on both internal and external resources. Biozep has established its own laboratory in Oslo in order to do synthesis, purification, quality control and chemical development in-house. The biological testing of the drug substances is performed in collaboration with carefully selected contract research organizations both in Europe and the USA. In order to reach the market as fast as possible and to reduce risk, Biozep will seek strategic partnerships early in the drug development phase. Biozep seeks partners with complementary competence and with resources to conduct clinical trials and with market access. We are already in dialogue with potential partners and hope to sign an agreement in 2018-19.

An intracellular approach to diagnostics – changing the way diagnostics approach blood tests. Pre Diagnostics is the first diagnostics company to focus on intracellular measurements of disease-specific biomarkers inside the blood cells. We extract disease-relevant information from biomarkers located inside specific blood cells called monocytes to provide actionable results for patients and practitioners.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

Aqua Alarm is developing a Biological Water Alarm System (BiWAS). There are three things that make BiWAS stand out from all other comparable products: 1) It provides real-time monitoring 2) It monitors a broad spectrum of toxicants, carcinogens and pathogens 3) It does this in a very cost-effective way We have among other things been through the av Horizon 2020 phase 1 project and are presently performing two projects to prove the technology in real environments. We are interested in industrial and development partners.

"Sammen om en jobb" (Together for a Job) is a Norwegian NGO running a mentor program between young immigrants and elderly Norwegians. The program has three principal aims:- transfer skills and knowledge from elderly people at the end of their professional careers to young immigrants just about to start theirs - provide a meaningful activity for people entering into retirement- support young immigrants in their job search- create relationships between different generations and cultures

We democratize e-commerce! We wish to make the process of selling and making money online available to everyone! Most of our users have never run an online store before, and we know that! That is why we have developed a solution that is so easy to use that anyone can set up and launch their own online store in just a few minutes. Yes, even you!